A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy Participants

Inclusion Criteria: * The participant is male or female 18 to 55 years of age, inclusive, at Screening. * The participant has a body mass index 18 to 32 kg/m\^2, inclusive, at Screening. * The participant is considered by the investigator to be in good general health as determined by medical history, clinical laboratory test results, vital sign measurements, 12-lead ECG results, and physical examination findings at Screening. * Male and female participants of reproductive potential must use an acceptable method of birth control (i.e., diaphragm with spermicide, intrauterine device, condom with foam or vaginal spermicide, oral contraceptives, or abstinence) from the signing of informed consent until 4 weeks after the last dose of study drug or be surgically sterile (i.e., vasectomy, hysterectomy, bilateral tubal ligation or bilateral oophorectomy) or postmenopausal (defined as amenorrhea for 12 consecutive months and documented plasma follicle stimulating hormone \[FSH\] level \>40 international unit (IU)/mL during Screening). * Female participants must have a negative pregnancy test at Screening and upon Check-in. * The participant agrees to comply with all protocol requirements. * The participant is able to provide written informed consent. Exclusion Criteria: * The participant has a positive test result for hepatitis B surface antigen, hepatitis C virus antibody, or human immunodeficiency virus types 1 or 2 antibodies at Screening. * The participant has a positive test r…